2015
DOI: 10.1158/1940-6207.capr-14-0229
|View full text |Cite
|
Sign up to set email alerts
|

Urinary ADAM12 and MMP-9/NGAL Complex Detect the Presence of Gastric Cancer

Abstract: Although the early diagnosis of gastric cancer provides the opportunity for curative endoscopic resection, comprehensive screening endoscopy would be invasive and expensive. To date, there is a complete absence of clinically useful gastric cancer biomarkers. With the goal of discovering noninvasive biomarkers for the early diagnosis of gastric cancer, we have conducted a case-control study using urine samples from individuals with gastric cancer versus healthy control samples. Of the enrolled 106 patients from… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
42
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(44 citation statements)
references
References 52 publications
1
42
0
Order By: Relevance
“…Moreover, MMP-9 levels were found to be significantly higher in the serum of gastric cancer patients when compared with those of controls [54]. Evaluation of urine samples from individuals with gastric cancer versus healthy controls also revealed that urinary MMP-9/NGAL complex was a potential biomarker of early-stage gastric cancer [57]. In addition, a number of meta-analyses found that overexpression of MMPs was associated with poor prognosis in gastric cancer patients, as was the case for MMP-9 and MMP-2 [50,51,56].…”
Section: Col6a3mentioning
confidence: 91%
“…Moreover, MMP-9 levels were found to be significantly higher in the serum of gastric cancer patients when compared with those of controls [54]. Evaluation of urine samples from individuals with gastric cancer versus healthy controls also revealed that urinary MMP-9/NGAL complex was a potential biomarker of early-stage gastric cancer [57]. In addition, a number of meta-analyses found that overexpression of MMPs was associated with poor prognosis in gastric cancer patients, as was the case for MMP-9 and MMP-2 [50,51,56].…”
Section: Col6a3mentioning
confidence: 91%
“…For example, gene-targeting strategies in mice indicate ADAM12 as a key regulator in myogenesis 12 and adipogenesis, 13 while in vitro studies have assigned roles for ADAM12 in promoting cell fusion in osteoclasts 14 and trophoblasts. 15 ADAM12 also positively associates, and in some cases promotes, the progression of chronic disease states including multiple subtypes of cancer, [16][17][18] fibrosis, 19 and cardiac hypertrophy. 20 The secreted variant, ADAM12S, strongly links with cancer progression where serum levels are elevated in patients with highly-invasive metastatic breast cancer, while ADAM12S over-expression promotes breast cancer cell invasion.…”
Section: Diverse Proteases Coordinate Invasive Trophoblast Biologymentioning
confidence: 99%
“…Indeed, the putative substrates of ADAM9, ADAM10 and ADAM17 identified by MS in CSF fluid, according to MEROPS, include amyloid beta A4 protein (Table S1, Supporting Information), supporting its involvement in AD pathogenesis. These ADAM proteases were already assessed in body fluids, mostly in blood‐derived ones, with ELISA approaches, and related with other pathological conditions besides AD …”
Section: Comparative Analysis Of Proteases Distribution Among Distincmentioning
confidence: 99%